-
Evaluating the Acceptability of Vignette Studies in Eliciting Utility Values for Rare Diseases: Perspectives From European HTA Agencies
Sep 9, 2025, 16:22 PM -
Patient Preference Studies in HTA for Rare Diseases: A Cross-Country Analysis of EU-4, UK, and Canada
Sep 9, 2025, 16:22 PM -
Fit-for-Purpose Real-World Data: Lessons From FDA QCARD and EMA Data Quality Framework
Sep 9, 2025, 16:22 PM -
The Cost of Pressure: Quantifying the Consequences of Clinical Strain in Ophthalmology
Sep 9, 2025, 16:22 PM -
Incidence of Neutropenia Adverse Events Identified in Electronic Healthcare Records Among Initiators of CDK4/6 Inhibitors With Advanced Breast Cancer in the UK
Sep 9, 2025, 16:22 PM -
Pharmacovigilance of Cannabis-Based Products in Brazil
Sep 9, 2025, 16:22 PM -
Workforce Matters: Defining Labor Input for Better Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Dominance in Economic Evaluation as a Leverage in Pharmaceutical Price Negotiation
Sep 9, 2025, 16:22 PM -
Subcutaneous vs. Intravenous Administration in Oncology: A Literature Review of Impacts on Patients, Providers, and Hospitals
Sep 9, 2025, 16:22 PM -
Systematic Literature Review (SLR) of First-Line (1L) Treatments of Patients With Advanced or Metastatic HER2-Positive Gastroesophageal Adenocarcinoma (GEA)
Sep 9, 2025, 16:22 PM -
Suicidal Behavior and Mortality Risk in Thyroid Cancer: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Systematic Review and Meta-Analysis of the Efficacy and Safety of Biologics in the Treatment of Ankylosing Spondylitis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer Alongside the LIBELULE Randomized Phase III Trial
Sep 9, 2025, 16:22 PM -
The Growing Role of Real-World Evidence (RWE) to Support Efficacy in EMA Oncology Approvals: Light at the End of the Tunnel
Sep 9, 2025, 16:22 PM -
Individual Therapy or No Therapy at All: Impact of Patient Individual Therapies As ACT in the German AMNOG Process
Sep 9, 2025, 16:22 PM -
Optimizing MASLD Diagnostic Protocols: A Microsimulation Analysis of Test Sensitivity Requirements
Sep 9, 2025, 16:22 PM -
The Impact of Annual Price Revision Based on External Reference Pricing on Medicines Between 2012 and 2023 in Portugal
Sep 9, 2025, 16:22 PM -
Strengthening Routine Childhood Immunization Post-COVID: Global Strategies to Improve Coverage and Equity
Sep 9, 2025, 16:22 PM -
Increased Functional Impairment Associated With Generalized Anxiety Disorder (GAD): Findings From a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Shortage of Antineoplastics and Supportive Medicines in Armenia
Sep 9, 2025, 16:22 PM